Michelle Xia

1.0k total citations
34 papers, 212 citations indexed

About

Michelle Xia is a scholar working on Statistics and Probability, Oncology and Epidemiology. According to data from OpenAlex, Michelle Xia has authored 34 papers receiving a total of 212 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Statistics and Probability, 9 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Michelle Xia's work include Statistical Methods and Bayesian Inference (8 papers), Statistical Methods and Inference (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Michelle Xia is often cited by papers focused on Statistical Methods and Bayesian Inference (8 papers), Statistical Methods and Inference (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Michelle Xia collaborates with scholars based in United States, China and Canada. Michelle Xia's co-authors include Paul Gustafson, Xinyu Wu, Lei Hua, Baiyong Li, Warren Michelow, M McGuire, Réka Gustafson, Mark Gilbert, David Moore and Reetesh K. Pai and has published in prestigious journals such as Blood, Cancer Research and American Journal of Epidemiology.

In The Last Decade

Michelle Xia

33 papers receiving 211 citations

Peers

Countries citing papers authored by Michelle Xia

Since Specialization

Citations

This map shows the geographic impact of Michelle Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle Xia more than expected).

Fields of papers citing papers by Michelle Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle Xia. The network helps show where Michelle Xia may publish in the future.

Co-authorship network of co-authors of Michelle Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle Xia. A scholar is included among the top collaborators of Michelle Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle Xia. Michelle Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study 2024 ·Oral Oncology ·Qiuyan Chen, Shanshan Guo, Ying Luo, Song Qu, Dehua Wu, Xiaozhong Chen, (unknown), (unknown), Qin Lin, Feng Jin, Shaojun Lin, (unknown), Wei Liu, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Rui‐Hua Xu, Lin‐Quan Tang, Hai‐Qiang Mai	11
2	Trial in Progress: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase 2 Study of AK117/Placebo in Combination with Azacitidine in Patients with Newly Diagnosed Higher-Risk Myelodysplastic Syndromes (AK117-205) 2024 ·Blood ·Amer M. Zeidan, (unknown), (unknown), (unknown), Ramzi Abboud, Christopher B. Benton, Joshua F. Zeidner, Uma Borate, Wanxing Chai‐Ho, Yonglin Lu, Jie Yang, Mingxiu Hu, (unknown), Michelle Xia, David A. Sallman	2
3	Ebronucimab in Chinese patients with hypercholesterolemia---A randomized double-blind placebo-controlled phase 3 trial to evaluate the efficacy and safety of ebronucimab 2024 ·Pharmacological Research ·Yanyan Zhang, Zhaohui Pei, (unknown), (unknown), Xiaolin Dong, (unknown), Guoqin Wang, (unknown), Dongmei Lu, (unknown), (unknown), (unknown), Max Wang, Baiyong Li, Michelle Xia, Bo Zheng, Yong Huo	3
4	The efficacy and safety of cadonilimab combined with lenvatinib for first-line treatment of advanced hepatocellular carcinoma (COMPASSION-08): a phase Ib/II single-arm clinical trial 2023 ·Frontiers in Immunology ·Qian Qiao, Chun Han, Sisi Ye, Juan Li, Guoliang Shao, Yuxian Bai, Aibing Xu, Meili Sun, Wei Wang, Jian Wu, Ming Huang, Lijie Song, (unknown), Ting Liu, Wei Liu, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Li Bai	30
5	Safety, Pharmacokinetics and Preliminary Efficacy of IL4-Rα Monoclonal Antibody AK120 in Both Healthy and Atopic Dermatitis Subjects: A Phase I, Randomized, Two-Part, Double-Blind, Placebo-Controlled, Dose-Escalation, First-In-Human Clinical Study 2023 ·Dermatology and Therapy ·Christopher Wynne, (unknown), Charlotte Lemech, (unknown), Yu Zhang, (unknown), Max Wang, Baiyong Li, Michelle Xia, Rodney Sinclair	8
6	Population pharmacokinetic/pharmacodynamic analysis of AK111, an IL-17A monoclonal antibody, in subjects with moderate-to-severe plaque psoriasis 2022 ·Frontiers in Pharmacology ·Qian Li, Ju Qiao, Hongzhong Jin, (unknown), (unknown), Guoqin Wang, (unknown), Max Wang, Michelle Xia, Baiyong Li, Rui Chen, Pei Hu	1
7	Abstract 5180: A randomized, double-blind, placebo-controlled phase III study to evaluate AK104 plus platinum-containing chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer 2022 ·Cancer Research ·Xiaohua Wu, Jing Wang, (unknown), Yuzhi Li, (unknown), Ke Wang, Michelle Xia, Baiyong Li, Wei Liu	1
8	Abstract 5524: AK127, a novel monoclonal antibody (mAb) targeting T cell immunoreceptor (TIGIT) 2022 ·Cancer Research ·(unknown), (unknown), Tingting Zhong, (unknown), Na Chen, (unknown), Peng Zhang, Max Wang, Michelle Xia, Baiyong Li	1
9	Population Pharmacokinetic Modeling and Exposure-Response Analysis Providing a Basis for Selecting Penpulimab Dose in a Population with Relapsed/Refractory Classic Hodgkin's Lymphoma 2021 ·Blood ·(unknown), (unknown), Yongcheng Dong, Max Wang, (unknown), Michelle Xia, (unknown)	1
10	A Bayesian mixture of experts approach to covariate misclassification 2020 ·Canadian Journal of Statistics ·Michelle Xia, P. Richard Hahn, Paul Gustafson	1
11	Rehabilitation technology services and employment outcomes among consumers using division of rehabilitation services 2018 ·Disability and Rehabilitation Assistive Technology ·(unknown), (unknown), (unknown), Michelle Xia	4
12	DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma 2018 ·Human Pathology ·Iván González, (unknown), Michelle Xia, Reetesh K. Pai, Changqing Ma	10
13	Bayesian Adjustment for Insurance Misrepresentation in Heavy-Tailed Loss Regression 2018 ·Risks ·Michelle Xia	2
14	Small Bowel Adenocarcinoma Frequently Exhibits Lynch Syndrome–associated Mismatch Repair Protein Deficiency But Does Not Harbor Sporadic MLH1 Deficiency 2016 ·Applied immunohistochemistry & molecular morphology ·Michelle Xia, Aatur D. Singhi, Beth Dudley, Randall E. Brand, Marina N. Nikiforova, Reetesh K. Pai	8
15	Assessing component reliability using lifetime data from systems 2016 ·Journal of Statistical Computation and Simulation ·Nader Ebrahimi, Michelle Xia, Lei Hua	3
16	Expression and clinical significance of epidermal growth factor receptor and insulin-like growth factor receptor 1 in patients with ampullary adenocarcinoma 2015 ·Human Pathology ·Michelle Xia, Michael J. Overman, Asif Rashid, Deyali Chatterjee, Hua Wang, Matthew H. G. Katz, Jason B. Fleming, Jeffery E. Lee, Gauri R. Varadhachary, Robert A. Wolff, Huamin Wang	7
17	A Bayesian Mixture Model Accounting for Zeros and Negatives in the Loss Triangle 2015 ·International Journal of Statistics and Probability ·Michelle Xia, David P. M. Scollnik	1
18	Boerhaave Syndrome Resulting From Homicidal Blunt Trauma 2014 ·American Journal of Forensic Medicine & Pathology ·Michelle Xia, (unknown)	1
19	Bayesian sensitivity analyses for hidden sub‐populations in weighted sampling 2014 ·Canadian Journal of Statistics ·Michelle Xia, Paul Gustafson	4
20	Impact of Statistical Adjustment for Frequency of Venue Attendance in a Venue-based Survey of Men Who Have Sex With Men 2013 ·American Journal of Epidemiology ·Paul Gustafson, Mark Gilbert, Michelle Xia, Warren Michelow, (unknown), Terry Trussler, M McGuire, Daniel Paquette, David Moore, Réka Gustafson	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact